Cargando…
Respiratory syncytial virus: The virus, the disease and the immune response
RSV is the primary cause of hospitalisation in the first year of life for children in most parts of the world, and nearly 100% of children in the USA are infected with the virus by 2 to 3 years of age. The agent is an enveloped RNA virus with a non-segmented single-stranded negative-sense genome. Th...
Autor principal: | Ogra, Pearay L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172639/ https://www.ncbi.nlm.nih.gov/pubmed/14980256 http://dx.doi.org/10.1016/S1526-0542(04)90023-1 |
Ejemplares similares
-
Respiratory syncytial virus
por: Ruuskanen, Olli, et al.
Publicado: (1993) -
Healthcare-associated respiratory syncytial virus infections in children’s hospitals
por: Saiman, Lisa, et al.
Publicado: (2022) -
Clinical and biological consequences of respiratory syncytial virus
genetic diversity
por: Rios Guzman, Estefany, et al.
Publicado: (2022) -
Surveillance towards preventing paediatric incidence of respiratory syncytial virus attributable respiratory tract infection in primary and secondary/tertiary healthcare settings in Merseyside, Cheshire and Bristol, UK
por: Fyles, Fred, et al.
Publicado: (2023) -
TMEM16A/ANO1 calcium-activated chloride channel as a novel target for the treatment of human respiratory syncytial virus infection
por: Pearson, Hayley, et al.
Publicado: (2021)